SHC

MKT CAP:$4B

Sotera Health Company

Market Cap

$4B

Healthcare·Medical - Diagnostics & Research·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$15.59-$2.10 (-11.85%)

Apr 22, 2026

Company Details

Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processi...

CEO

Michael Petras Jr.

IPO Date

Nov 20, 2020

Website

soterahealth.com

Key Metrics TTM

Revenue

$1.1B

+7.8% YoY

Net Income

$24M

EPS (Diluted)

$0.08

Free Cash Flow

$111M

Revenue / Share

$3.94

Gross Margin

55.5%

Operating Margin

27.8%

Net Margin

2.1%

FCF Margin

9.9%

P/S

3.9x

P/E

183.9x

Earnings Reports

Q3 2025

May 7, 2026

PENDING

FY 2025

Feb 24, 2026

$1.2B+5.7%EPS $0.27

Q2 2025

Aug 8, 2025

$294M+6.4%EPS $0.03

Q1 2025

May 1, 2025

$255M+2.6%EPS -$0.05

FY 2024

Feb 27, 2025

$1.1B+4.9%EPS $0.16

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 21	$252M	$144M	$78M
Q3 21	$226M	$126M	$66M
Q4 21	$241M	$134M	$66M
Q1 22	$237M	$129M	$53M
Q2 22	$267M	$150M	$71M
Q3 22	$249M	$136M	$63M
Q4 22	$252M	$142M	$60M
Q1 23	$221M	$112M	$33M
Q2 23	$255M	$140M	$63M
Q3 23	$263M	$146M	$76M
Q1 24	$248M	$127M	$53M
Q2 24	$277M	$153M	$77M
Q3 24	$285M	$158M	$81M
Q4 24	$290M	$164M	$87M
Q1 25	$255M	$135M	$57M
Q2 25	$294M	$167M	$88M

Valuation

Quarter	P/S	P/E
Q2 21	—	—
Q3 21	8.4x	88.5x
Q4 21	7.1x	57.9x
Q1 22	6.4x	44.8x
Q2 22	6.0x	46.4x
Q3 22	2.1x	16.9x
Q4 22	2.4x	—
Q1 23	5.0x	—
Q2 23	5.3x	—
Q3 23	4.2x	—
Q1 24	3.4x	174.0x
Q2 24	3.1x	131.5x
Q3 24	4.4x	256.4x
Q4 24	3.4x	85.1x
Q1 25	3.0x	133.2x
Q2 25	2.8x	131.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 21	$78M	$54M
Q3 21	$81M	$65M
Q4 21	$66M	$25M
Q1 22	$50M	$14M
Q2 22	$58M	$22M
Q3 22	$68M	$29M
Q4 22	$102M	$30M
Q1 23	$34M	-$11M
Q2 23	-$337M	-$390M
Q3 23	$42M	-$10M
Q1 24	$10M	-$25M
Q2 24	$61M	$19M
Q3 24	$96M	$59M
Q4 24	$56M	-$10M
Q1 25	$56M	$36M
Q2 25	$57M	$26M

Capital Expenditures

Quarter	CapEx
Q2 21	$24M
Q3 21	$16M
Q4 21	$41M
Q1 22	$36M
Q2 22	$36M
Q3 22	$39M
Q4 22	$72M
Q1 23	$45M
Q2 23	$53M
Q3 23	$52M
Q1 24	$35M
Q2 24	$42M
Q3 24	$36M
Q4 24	$66M
Q1 25	$20M
Q2 25	$31M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 21	+23.9%	+22.8%
Q1 22	+21.6%	+28.7%
Q2 22	+5.8%	+12.4%
Q3 22	+10.0%	+15.6%
Q4 22	+4.3%	+9.5%
Q1 23	-6.8%	+2.2%
Q2 23	-4.3%	-1.6%
Q3 23	+5.8%	+0.8%
Q1 24	-1.4%	+1.9%
Q2 24	+25.4%	+6.7%
Q3 24	+11.8%	+6.7%
Q4 24	+10.3%	+8.5%
Q1 25	+2.6%	+1.3%
Q2 25	+6.4%	+3.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 21	$3M	1.4%
Q3 21	$4M	1.6%
Q4 21	$3M	1.4%
Q1 22	$5M	1.9%
Q2 22	$6M	2.2%
Q3 22	$5M	1.9%
Q4 22	$6M	2.5%
Q1 23	$7M	3.3%
Q2 23	$8M	3.3%
Q3 23	$8M	3.2%
Q1 24	$9M	3.5%
Q2 24	$10M	3.7%
Q3 24	$10M	3.4%
Q4 24	$8M	2.8%
Q1 25	$0	0.0%
Q2 25	$8M	2.8%

OpEx Breakdown

Quarter	SG&A
Q2 21	$50M
Q3 21	$44M
Q4 21	$52M
Q1 22	$60M
Q2 22	$63M
Q3 22	$57M
Q4 22	$66M
Q1 23	$62M
Q2 23	$60M
Q3 23	$54M
Q1 24	$58M
Q2 24	$61M
Q3 24	$62M
Q4 24	$62M
Q1 25	$63M
Q2 25	$69M

Revenue Segments

Quarter	Product	Service
Q2 21	$43M	$209M
Q3 21	$26M	$200M
Q4 21	$34M	$208M
Q1 22	$31M	$206M
Q2 22	$45M	$222M
Q3 22	$32M	$217M
Q4 22	$31M	$220M
Q1 23	$6M	$215M
Q2 23	$29M	$226M
Q3 23	$36M	$227M
Q1 24	$22M	$226M
Q2 24	$39M	$238M
Q3 24	$47M	$239M
Q4 24	$51M	$239M
Q1 25	$31M	$224M
Q2 25	$37M	$257M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$121M	$0	$121M
Q2 22	$140M	$0	$140M
Q3 22	$164M	$0	$164M
Q4 22	$395M	$0	$395M
Q1 23	$648M	$0	$648M
Q2 23	$263M	$0	$263M
Q3 23	$245M	$0	$245M
Q4 23	$296M	$0	$296M
Q1 24	$261M	$0	$261M
Q2 24	$246M	$0	$246M
Q3 24	$307M	$0	$307M
Q4 24	$277M	$0	$277M
Q1 25	$304M	$0	$304M
Q2 25	$332M	$0	$332M
Q3 25	$301M	$0	$301M
Q4 25	$346M	$0	$346M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 21	279M	+20.1%	—
Q3 21	280M	+0.1%	—
Q4 21	280M	+0.1%	+20.4%
Q1 22	280M	+0.0%	+20.4%
Q2 22	280M	+0.1%	+0.3%
Q3 22	280M	+0.0%	+0.2%
Q4 22	280M	+0.1%	+0.2%
Q1 23	283M	+0.9%	+1.1%
Q2 23	283M	+0.1%	+1.1%
Q3 23	281M	-0.7%	+0.3%
Q1 24	284M	+1.1%	+1.3%
Q2 24	285M	+0.2%	+0.6%
Q3 24	286M	+0.4%	+0.9%
Q4 24	285M	-0.2%	+1.4%
Q1 25	284M	-0.5%	-0.2%
Q2 25	286M	+0.8%	+0.4%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 21	$84.0K	3K
Q3 21	$75.4K	3K
Q4 21	$80.4K	3K
Q1 22	$78.9K	3K
Q2 22	$88.9K	3K
Q3 22	$82.9K	3K
Q4 22	$83.9K	3K
Q1 23	$73.5K	3K
Q2 23	$85.1K	3K
Q3 23	$87.7K	3K
Q1 24	$82.7K	3K
Q2 24	$92.2K	3K
Q3 24	$95.2K	3K
Q4 24	$96.7K	3K
Q1 25	$84.8K	3K
Q2 25	$98.1K	3K

Revenue / Employee